Home Newsletters Endothelial Cell News A Novel Personalized Treatment Approach for Psoriasis: Anti-VEGF-A Therapy

A Novel Personalized Treatment Approach for Psoriasis: Anti-VEGF-A Therapy

0
Vascular endothelial growth factor A (VEGF-A) mediates angiogenesis and is upregulated in the plaques and plasma of patients with psoriasis. Targeting VEGF-A in in vivo models of psoriasis-like inflammation results in disease clearance.
[British Journal of Dermatology]

Sorry, but the selected Zotpress account can't be found.

Abstract
Exit mobile version